Diabetes 62:A257A257 Henderson SJ, Konkar A, Hornigold DC et al (2016) Robust anti-obesity and metabolic effects of a dual GLP-1/glucagon receptor peptide agonist in rodents and non-human primates
It helps regulate blood sugar levels, slows gastric emptying, and promotes a sense of fullness after eating, which can contribute to reduced calorie intake over time
Media Contact: Jacky Chou Business Name: Indexsy Consulting Ltd
reports interests in Ropirio Therapeutics, Earli Inc., Sunbird Bio, Satellite Bio, Catalio Capital, Port Therapeutics, Matrisome Bio, Xilio Therapeutics, Ochre Bio, Impilo Therapeutics, Vertex Pharmaceuticals, Moderna, Johnson & Johnson and Owlstone, which were not involved in this study